Cardiff Oncology, Inc. - Common Stock (CRDF)

CUSIP: 14147L108

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
66,577,393
Total 13F shares
25,201,266
Share change
-3,454,407
Total reported value
$51,916,152
Put/Call ratio
14%
Price per share
$2.06
Number of holders
111
Value change
-$9,684,486
Number of buys
50
Number of sells
49

Quarterly Holders Quick Answers

What is CUSIP 14147L108?
CUSIP 14147L108 identifies CRDF - Cardiff Oncology, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Cardiff Oncology, Inc. - Common Stock (CRDF) as of Q3 2025

As of 30 Sep 2025, Cardiff Oncology, Inc. - Common Stock (CRDF) was held by 111 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,201,266 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Laurion Capital Management LP, Pfizer Inc, BLAIR WILLIAM & CO/IL, ACORN CAPITAL ADVISORS, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, FLPUTNAM INVESTMENT MANAGEMENT CO, and NORTHERN TRUST CORP. This page lists 111 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.